Alrise Biosystems GmbH

📍 Berlin, Germany👥 9 employees💰 Last funded Dec 2005
Pharmaceuticals🌐 alrise.de
Website LinkedIn
ALRISE develops controlled release depot formulations for protein, peptide and small molecule drugs. The cornerstone of ALRISE’s business is its patented parenteral drug delivery technology ImSus® for the encapsulation of active pharmaceutical ingredients in biodegradable polymeric nano- or microparticles. ALRISE offers its technology and experience to pharma-, biotech- and generic drug companies with the objective of developing new products or improving current products based on controlled release formulations. Business Areas The development of innovative solutions for target product profiles given by its partners is ALRISE’s core competence. Services mainly apply to areas of - Formulation of New Chemical Entities (in co-operation with drug developing companies) - Reformulation of pharmaceutical products in the context of Product Lifecycle Management (in co-operation with originators) - Reformulation of off-patent drugs to develop supergeneric products (in co-operation with generics companies)
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Alrise Biosystems GmbH?
Alrise Biosystems GmbH has 1 investors on record on gritt.io.
When did Alrise Biosystems GmbH last raise funding?
The most recent investment in Alrise Biosystems GmbH recorded on gritt.io was in December 2005.
What industry is Alrise Biosystems GmbH in?
Alrise Biosystems GmbH operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is Alrise Biosystems GmbH based?
Alrise Biosystems GmbH is headquartered in Berlin, Germany.